Cooper Companies, Inc. (COO) stock
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 16/3040% below fair value
$60.72−1.16 (-1.87%)
Close on Nov 17, 2026Market cap $11.55BP/E 20.7Yield –
Cooper Companies total assets
Total assets on the balance sheet at the end of each period.
Cooper Companies's total assets was $12.67B at Jul 31, 2026. For fiscal 2025 it was $12.39B, up 0.6% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $12.39B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $12.39B | +0.6% |
| FY2024 | Oct 31, 2024 | $12.32B | +5.6% |
| FY2023 | Oct 31, 2023 | $11.66B | +1.4% |
| FY2022 | Oct 31, 2022 | $11.49B | +19.6% |
| FY2021 | Oct 31, 2021 | $9.61B | +42.6% |
| FY2020 | Oct 31, 2020 | $6.74B | +7.4% |
| FY2019 | Oct 31, 2019 | $6.27B | +2.6% |
| FY2018 | Oct 31, 2018 | $6.11B | +25.8% |
| FY2017 | Oct 31, 2017 | $4.86B | +8.5% |
| FY2016 | Oct 31, 2016 | $4.48B | +0.4% |
| FY2015 | Oct 31, 2015 | $4.46B | +0.1% |
| FY2014 | Oct 31, 2014 | $4.46B | +42.1% |
| FY2013 | Oct 31, 2013 | $3.14B | +6.7% |
| FY2012 | Oct 31, 2012 | $2.94B | +12.1% |
| FY2011 | Oct 31, 2011 | $2.62B | +3.9% |
| FY2010 | Oct 31, 2010 | $2.53B | -1.1% |
| FY2009 | Oct 31, 2009 | $2.55B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $12.67B | +2.4% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $12.48B | +0.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $12.42B | +1.7% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $12.39B | +0.6% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $12.38B | +2.2% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $12.41B | +3.0% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $12.22B | +1.6% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $12.32B | +5.6% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $12.11B | +3.5% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $12.05B | +4.4% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $12.03B | +4.1% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $11.66B | +1.4% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $11.70B | +1.3% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $11.54B | -2.0% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $11.56B | -0.9% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $11.49B | +19.6% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $11.55B | +20.2% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $11.78B | +30.7% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $11.66B | +30.7% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $9.61B | +42.6% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $9.61B | +42.4% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $9.01B | +38.5% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $8.92B | +36.2% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $6.74B | +7.4% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $6.75B | +9.3% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $6.51B | +4.9% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $6.55B | +4.0% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $6.27B | +2.6% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $6.17B | -1.3% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $6.20B | -3.3% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $6.30B | +0.5% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $6.11B | +25.8% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $6.26B | +30.8% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $6.41B | +35.0% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $6.27B | +34.6% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $4.86B | +8.5% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $4.78B | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $4.75B | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $4.66B | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $4.48B | – |
See a number that looks wrong?